{"anticipatedPostingDate":"2027-01","denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"From randomization (Day -5) up to 8 years","title":"Percentage of Participants Who Progressed to Multiple Myeloma With Adverse Prognostic Features","type":"SECONDARY"}